Safety And Pharmacokinetics Of Oral Cannabidiol When Administered Concomitantly With Intravenous Fentanyl In Humans

Pain (Chronic Non-Malignant) Addiction to Opiod Based Pain Killers

Key Findings

Cannabidiol does not exacerbate adverse effects associated with intravenous fentanyl administration. Coadministration of CBD and opioids was safe and well tolerated. These data provide the foundation for future studies examining CBD as a potential treatment for opioid abuse.

Information and Links


Link: Safety And Pharmacokinetics Of Oral Cannabidiol When Administered Concomitantly With Intravenous Fentanyl In Humans

Year: 2015

DOI: 10.1097/ADM.0000000000000118.


Ratings

(How Ratings Work)

Pain (Chronic Non-Malignant) — 4


Probability toward demonstrable efficacy of cannabis for treatment of Pain (Chronic Non-Malignant) according to the results found in this study.

Addiction to Opiod Based Pain Killers — 4


Probability toward demonstrable efficacy of cannabis for treatment of Addiction to Opiod Based Pain Killers according to the results found in this study.

Drugs Used

CBD and fentanyl